DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
Aktueller Standort:
> This Story

starstarstarstarstar (1)
Log in oder Register to rate this News Story
Forward Printable StoryPrint Comment




Cardiology Homepage

Evaluating the cost-effectiveness of AEDs in the U.S. Insights from Dr. Lars W. Andersen on research he conducted and what it should mean for the future of public defibrillators

The 2019 Heart Rhythm Society scientific sessions: advanced technology in electrophysiology Four key takeaways

New machine learning algorithm could decide who is best for heart failure treatment Could help prevent sudden death from heart failure

Philips teams with Medtronic on cryoablation treatment for atrial fibrillation Will form an integrated solution for cryoablation

Varian acquires CyberHeart, enters cardiac radioablation market Emerging technology could benefit treatment of irregular heartbeats

FDA gives thumbs-up for Biofourmis’ RhythmAnalytics AI Platform Provides automated interpretations of cardiac arrhythmias

Using comic illustrations to support patient understanding of cardiac catheterization Making patients more satisfied, less anxious and more informed

Medical community finds ways to make TAVR safer for at-risk patients Improving outcomes with special procedures

New ultrasound tech could help detect pediatric congenital heart disease Visualizes structure and blood flow of babies' hearts

Mick Jagger resting after TAVR heart surgery The 75 year old rock star is reportedly recovering from the operation at New York Presbyterian

Israeli researchers have developed
the first 3D heart comprised
of blood vessels and cells

Israeli researchers develop first 3D heart from patient's biological materials

by John R. Fischer , Staff Reporter
Israeli researchers have developed the first 3D printed, vascularized engineered heart comprising a patient’s own cells and biological materials.

The 3D organ is the first to consist of blood vessels and cells, and is considered a step toward ensuring access to a greater number of heart transplants that carry less risk of being rejected by the body, says the team at Tel Aviv University.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED

"This is the first time anyone, anywhere has successfully engineered and printed an entire heart, replete with cells, blood vessels, ventricles and chambers," professor Tal Dvir of TAU's School of Molecular Cell Biology and Biotechnology, and leader of the study, said in a statement.

The number one cause of death for men and women in the U.S., heart disease often leads to end-stage heart failure, a condition that can only be treated with a transplant. Access to these transplants, however, is limited by a shortage of available donors. There is also the risk of rejection by the body.

The 3D organ is composed of human cells, and patient-specific biological materials that act as bioinks, and are made up of sugars and proteins used for 3D printing of complex tissue models.

Utilizing a biopsy of fatty tissue taken from patients, the researchers separated the cellular and acellular materials and reprogrammed the cells to become pluripotent stem cells. They then processed the extracellular matrix into a personalized hydrogel to serve as the printing "ink", and mixed it with the cells to differentiate cardiac from endothelia cells.

This enabled them to create patient-specific, immune-compatible patches with blood vessels, followed by an entire heart.

The organ in question is the size of a rabbit’s heart but the same technology is necessary for the creation of a human-sized one. The authors plan to transplant their creation in animal models once they have cultured them in the lab and "taught" them to "behave" as hearts.

"We need to develop the printed heart further," said Dvir. "The cells need to form a pumping ability; they can currently contract, but we need them to work together. Our hope is that we will succeed and prove our method's efficacy and usefulness. Maybe, in ten years, there will be organ printers in the finest hospitals around the world, and these procedures will be conducted routinely."

Research was conducted by Dvir; Dr. Assaf Shapira of TAU's Faculty of Life Sciences; and Nadav Moor, a doctoral student in Dvir's lab.

The findings were published in the journal, Advanced Science.

Back to HCB News
  Pages: 1

Cardiology Homepage

You Must Be Logged In To Post A Comment

Erhöhen Sie Ihren Bekanntheitsgrad
Auktionen + Privatverkäufe
Den besten Preis erzielen
Geräte/Geräteteile kaufen
Den günstigsten Preis finden
Daily News
Die neuesten Nachrichten lesen
Alle DOTmed Benutzer durchsuchen
Ethik auf DOTmed
Unseren Ethik-Standard anzeigen
Gold-Parts Verkäufer-Programm
PH-Anfragen erhalten
Gold Service Dealer-Programm
Anfragen empfangen
Alle Gesundheitsdienstleister-Tools anzeigen
Einen Job suchen
Parts Hunter +EasyPay
Angebote für Geräteteile erhalten
Kürzlich zertifiziert
Kürzlich zertifizierte Benutzer anzeigen
Kürzlich bewertet
Kürzlich zertifizierte Benutzer anzeigen
Rental Central
Geräte billiger mieten
Geräte/Geräteteile verkaufen
Das meiste Geld erhalten
Service-Techniker Forum
Hilfe und Beratung finden
Einfache Angebots-Anfrage
Angebote für Geräte erhalten
Virtuelle Messe
Service für Geräte finden
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2019, Inc.